DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Enclomiphene is an investigational drug.
There have been 21 clinical trials for Enclomiphene. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2006.
The most common disease conditions in clinical trials are Hypogonadism, Neoplasm Metastasis, and Renal Insufficiency. The leading clinical trial sponsors are Repros Therapeutics Inc., Woman's Health University Hospital, Egypt, and Celerion.
Recent Clinical Trials for Enclomiphene
|A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene||Repros Therapeutics Inc.||Phase 2|
|Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome||Woman's Health University Hospital, Egypt||Phase 2|
|Androxal in Male Infertility||Baylor College of Medicine||Phase 2/Phase 3|